Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 2
2003 1
2007 1
2008 3
2009 1
2013 2
2014 3
2015 4
2016 7
2017 3
2018 4
2019 6
2020 4
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J. Whiting PF, et al. Among authors: kleijnen j. JAMA. 2015 Jun 23-30;313(24):2456-73. doi: 10.1001/jama.2015.6358. JAMA. 2015. PMID: 26103030 Review.
Compared with placebo, cannabinoids were associated with a greater average number of patients showing a complete nausea and vomiting response (47% vs 20%; odds ratio [OR], 3.82 [95% CI, 1.55-9.42]; 3 trials), reduction in pain (37% vs 31%; OR, 1.41 [95% CI, 0.99-2.00]; 8 trials), …
Compared with placebo, cannabinoids were associated with a greater average number of patients showing a complete nausea and vomiting respons …
A systematic approach to searching: an efficient and complete method to develop literature searches.
Bramer WM, de Jonge GB, Rethlefsen ML, Mast F, Kleijnen J. Bramer WM, et al. Among authors: kleijnen j. J Med Libr Assoc. 2018 Oct;106(4):531-541. doi: 10.5195/jmla.2018.283. Epub 2018 Oct 1. J Med Libr Assoc. 2018. PMID: 30271302 Free PMC article.
This method describes how single-line search strategies can be prepared in a text document by typing search syntax (such as field codes, parentheses, and Boolean operators) before copying and pasting search terms (keywords and free-text synonyms) that are found in the thesaurus. …
This method describes how single-line search strategies can be prepared in a text document by typing search syntax (such as field codes, par …
Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis.
Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J. Whiting P, et al. Among authors: kleijnen j. Health Technol Assess. 2015 Jul;19(58):1-228, v-vi. doi: 10.3310/hta19580. Health Technol Assess. 2015. PMID: 26215747 Free PMC article. Review.
The health-economic analysis considered the costs and quality-adjusted life-years of ROTEM, TEG and Sonoclot compared with SLTs in cardiac surgery and trauma patients. A decision tree was used to take into account short-term complications and longer-term side effect …
The health-economic analysis considered the costs and quality-adjusted life-years of ROTEM, TEG and Sonoclot compared with SLTs in cardiac s …
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.
Westwood M, Ramaekers B, Grimm S, Worthy G, Fayter D, Armstrong N, Buksnys T, Ross J, Joore M, Kleijnen J. Westwood M, et al. Among authors: kleijnen j. Health Technol Assess. 2021 May;25(33):1-276. doi: 10.3310/hta25330. Health Technol Assess. 2021. PMID: 34061019 Free PMC article.
The bivariate model was used to estimate summary sensitivity and specificity for meta-analyses involving four or more studies; otherwise, random-effects logistic regression was used. The health economic analysis considered the long-term costs and quality-adjusted life-year …
The bivariate model was used to estimate summary sensitivity and specificity for meta-analyses involving four or more studies; otherwise, ra …
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Orozco Leal G, Armstrong N, Kernohan A, Ahmadu C, Coughlan D, McDermott K, Duffy S, O'Meara S, Robinson T, Vale L, Kleijnen J. Orozco Leal G, et al. Among authors: kleijnen j. Pharmacoeconomics. 2023 Jul;41(7):741-750. doi: 10.1007/s40273-023-01259-6. Epub 2023 Mar 23. Pharmacoeconomics. 2023. PMID: 36952138 Free PMC article. Review.
The ERG believed that the modelling structure presented in the de novo economic model by the company was appropriate but highlighted several areas of uncertainty that had the potential to have a significant impact on the resulting incremental cost-effectiveness ratio (ICER). Area …
The ERG believed that the modelling structure presented in the de novo economic model by the company was appropriate but highlighted several …
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
Swift SL, Puehler T, Misso K, Lang SH, Forbes C, Kleijnen J, Danner M, Kuhn C, Haneya A, Seoudy H, Cremer J, Frey N, Lutter G, Wolff R, Scheibler F, Wehkamp K, Frank D. Swift SL, et al. Among authors: kleijnen j. BMJ Open. 2021 Dec 6;11(12):e054222. doi: 10.1136/bmjopen-2021-054222. BMJ Open. 2021. PMID: 34873012 Free PMC article.
TAVI may reduce the risk of certain side effects while SAVR may reduce the risk of others. Most long-term (5-year) results are limited to older patients at high surgical risk (ie, early trials), therefore more data are required for low risk populations. ...
TAVI may reduce the risk of certain side effects while SAVR may reduce the risk of others. Most long-term (5-year) results are limite …
The Association of Coloproctology of Great Britain and Ireland guideline on the management of anal fissure.
Cross KLR, Brown SR, Kleijnen J, Bunce J, Paul M, Pilkington S, Warren O, Jones O, Lund J, Goss HJ, Stanton M, Marunda T, Gilani A, Ngu LWS, Tozer P. Cross KLR, et al. Among authors: kleijnen j. Colorectal Dis. 2023 Dec;25(12):2423-2457. doi: 10.1111/codi.16762. Epub 2023 Nov 5. Colorectal Dis. 2023. PMID: 37926920 Review.
RESULTS: This guideline is divided into two sections: Primary care which includes (i) diagnosis; (ii) basic treatment; (iii) topical treatment; and secondary care which includes (iv) botulinum toxin therapy; (v) surgical intervention and (vi) special situations (including pregnan …
RESULTS: This guideline is divided into two sections: Primary care which includes (i) diagnosis; (ii) basic treatment; (iii) topical treatme …
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Otten T, Riemsma R, Wijnen B, Armstrong N, Stirk L, Gordon C, Ramaekers B, Kleijnen J, Joore M, Grimm S. Otten T, et al. Among authors: kleijnen j. Pharmacoeconomics. 2022 Sep;40(9):851-861. doi: 10.1007/s40273-022-01166-2. Epub 2022 Jul 8. Pharmacoeconomics. 2022. PMID: 35802295 Free PMC article. Review.
The ERG identified three major concerns with the evidence presented on the clinical effectiveness in the current submission; namely, short follow-up in the main comparative trials (BLISS-SC, BLISS-52 and BLISS-76); using the propensity score-matching (PSM) analysis in calibrating …
The ERG identified three major concerns with the evidence presented on the clinical effectiveness in the current submission; namely, short f …
Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal.
Thielen FW, Büyükkaramikli NC, Riemsma R, Fayter D, Armstrong N, Wei CY, Huertas Carrera V, Misso K, Worthy G, Kleijnen J, Corro Ramos I. Thielen FW, et al. Among authors: kleijnen j. Pharmacoeconomics. 2019 Aug;37(8):975-984. doi: 10.1007/s40273-018-0740-4. Pharmacoeconomics. 2019. PMID: 30547368 Free PMC article. Review.
Most evidence on obinutuzumab was based on the GALLIUM trial that compared obinutuzumab in combination with chemotherapy as induction followed by obinutuzumab maintenance monotherapy with rituximab in combination with chemotherapy as induction followed by rituximab maintenance mo …
Most evidence on obinutuzumab was based on the GALLIUM trial that compared obinutuzumab in combination with chemotherapy as induction follow …
46 results